iBio, Inc.IBIONYSE
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR-27.7%
5Y CAGR-31.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-27.7%/yr
vs +9.2%/yr prior
5Y CAGR
-31.1%/yr
Recent acceleration
Acceleration
-36.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.58M | -39.6% |
| 2024 | $14.21M | +94.0% |
| 2023 | $7.33M | -67.7% |
| 2022 | $22.68M | -70.7% |
| 2021 | $77.40M | +40.4% |
| 2020 | $55.11M | +1146.6% |
| 2019 | $4.42M | -72.3% |
| 2018 | $15.93M | +97.0% |
| 2017 | $8.09M | -64.9% |
| 2016 | $23.01M | - |